Igusol Advance has recently published its new research on IGUSAFE applied on broilers fed up to 42 days. It has been conducted by the Faculty of Agriculture at Dicle University in Turkey, and it shows a significant improvement of body weight gains, a reduction of Aspartate Aminotransferase (AST) and Serum Total Protein levels compared with control group.
The study evaluated IGUSAFE at two inclusion levels on growth performance, intestinal microflora population and serum biochemistry in broilers.
As expected, Results showed that the addition of 80 mg IGUSAFE to the diet resulted in significantly higher body weight gains, and lower Aspartate Aminotransferase and Serum Total Protein levels compared with control group. Supplementing both levels of IGUSAFE significantly reduced Escherichia coli count.
The positive effects of IGUSAFE inclusion in feeding broilers program up to 42 days indicate that IGUSAFE is useful as enhancer of growth performance by reducing Escherichia coli, leading to a positive trend to broilers mortality reduction and thus, cost-effective benefits for the feed producer and farmer.